On Thursday, Shares of Host Hotels and Resorts Inc (NYSE:HST), added 0.91% and closed at $15.55 in the last trading session. The last trading range of the stock ranges between $15.25 and $15.64. Host Hotels & Resorts, Inc. is a publicly owned real estate investment trust (REIT). The firm mainly engages in the ownership and operation of hotel properties. It invests in the real estate markets of United States. It also invests in Canada, Mexico, Chile, the United Kingdom, Italy, Spain, and Poland. The firm mainly invests in luxury and upper upscale hotels.
Endo International plc – Ordinary Shares (NASDAQ:ENDP), dropped -3.69% and closed at $20.63 in the last trading session. The last trading range of the stock ranges between $20.43 and $21.27. The company’s Market capitalization is $4.77 Billion with the total Outstanding Shares of 222.77 million. Endo Pharmaceuticals Inc., a partner of Endo International plc (ENDP) (ENL.TO), recently declared new data to be presented evaluating the safety and efficacy of XIAFLEX®(collagenase clostridium histolyticum) (or CCH) injection under investigation for the treatment of palmar Dupuytren’s disease nodules. The findings will be presented during a podium presentation on Saturday, October 1, 2016 at 10:40 a.m. CDT at the annual meeting of the American Society for Surgery of the Hand (ASSH) held from September 29 to October 1, 2016 in Austin, Texas.
In a Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study, in 75 adult study participants with Dupuytren’s disease and at least 1 nodule who received a single injection of CCH 0.40 mg or 0.60 mg, a statistically noteworthydecrease was shown from baseline in the mean nodule surface area (P≤0.001), consistency score (P<0.001) and hardness score (P≤0.01) at week 8 as compared to study participants receiving placebo. The safety profile of those treated with CCH was generally well tolerated. Adverse events included extremity pain, axillary pain, injection site-related adverse events and pruritus. One adverse event was stated as severe (injection site pain with CCH 0.60 mg). No patients were suspended from the study because of an adverse event.
Companhia Energetica Minas Gerais (ADR)(NYSE: ), lost -0.74% and closed at $2.69 in the last trading session. The last trading range of the stock ranges between $2.63 and $2.70. During the 52-week trading session the minimum price at which share price traded, registered at $1.02 and reached to max level of $3.08. Companhia Energética de Minas Gerais S.A., through its auxiliaries, engages in the generation, transmission, distribution, and trading of electric energy in Brazil. It also distributes natural gas.